High expression of ETAR/IQGAP1/β-arrestin1 positively correlates with poor prognosis in ovarian carcinoma patients (Chellini et al., 2019), suggesting that the IQGAP1:β-arrestin1 interaction could contribute to ovarian carcinoma. The gene discussed is EDNRA; the disease is ovarian carcinoma.